Patents by Inventor Marina Matos De Moura

Marina Matos De Moura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists
    Patent number: 8586054
    Abstract: The present invention is characterized by the use of Mas-G-protein-coupled receptor agonists for the control, prevention and treatment of the body levels of triglycerides, cholesterol and glucose, as well as of hyper-tension and possible increase in body weight, which are characteristic of the clinical manifestation of the metabolic syndrome and its complications. Another characteristic of the invention is the use of Mas-G-protein-coupled receptor agonists, including the Angiotensin-(1-7) peptide and its analogs, agonists, either peptidic or non-peptidic, as modulators of the manifestations of insulin resistance and glucose intolerance and in the prevention and treatment of the related alterations.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: November 19, 2013
    Assignees: Max-Delbruck-Centrum fur Molekulare Medizin, Universidade Federal de Minas Gerais
    Inventors: Robson Augusto Souza Dos Santos, Sergio Henrique Sousa Santos, Jaqueline Isaura Alvarez Leite, Marina Matos De Moura, Andrea Siqueira Haibara, Luciana Rodriques Fernandez, Michael Bader, Natalia Alenina, Rubens Dario Sinisterra
  • Use of Mas-G-Protein-Coupled Receptor Agonists in the Treatment of the Metabolic Syndrome, Its Components and its Complications
    Publication number: 20090221498
    Abstract: The present invention is characterized by the use of Mas-G-protein-coupled receptor agonists for the control, prevention and treatment of the body levels of triglycerides, cholesterol and glucose, as well as of hyper-tension and possible increase in body weight, which are characteristic of the clinical manifestation of the metabolic syndrome and its complications. Another characteristic of the invention is the use of Mas-G-protein-coupled receptor agonists, including the Angiotensin-(1-7) peptide and its analogs, agonists, either peptidic or non-peptidic, as modulators of the manifestations of insulin resistance and glucose intolerance and in the prevention and treatment of the related alterations.
    Type: Application
    Filed: April 26, 2007
    Publication date: September 3, 2009
    Inventors: Robson Augusto Souza Dos Santos, Sergio Henrique Sousa Santos, Jaqueline Isaura Alvarez Leite, Marina Matos De Moura, Andrea Siqueira Haibara, Luciana Rodriques Fernandez, Michael Bader, Natalia Alenina, Rubens Dario Sinisterra